The Carlos Simon Foundation is partnering with CENTOGENE to support the development of next-generation diagnostic tools in reproductive genetics. This collaboration brings together CENTOGENE’s clinical data expertise and our scientific knowledge in female reproductive health, with the shared goal of improving diagnosis and personalized care for women worldwide.
Our research in areas such as the endometrial microbiome, maternal-fetal communication, and transcriptomic profiling of the uterus provides a strong foundation for innovative diagnostic solutions. By contributing our data and insights, we aim to accelerate the clinical application of discoveries that benefit patients and advance precision medicine in reproductive health.
This alliance reflects our mission to bridge science and society through translational research and to contribute meaningfully to the development of accessible, effective healthcare solutions for women.